Patient characteristics at diagnosis according to the major types of relapse
| . | λ (%) . | κ (%) . | Median iFLC level, mg/L . | iFLC >100 mg/L (%) . | Urine iFLC >200 mg/24 h (%) . | Thalidomide-based induction (%) . |
|---|---|---|---|---|---|---|
| FLC escape | 21 (39) | 33 (61) | 1040 | 48 (89) | 39 (72) | 23 (43) |
| PCL | 62 (34) | 121 (66) | 719.5 | 164 (89) | 118 (65) | 93 (51) |
| PO | 84 (33) | 174 (67) | 84.63 | 127 (49) | 99 (38) | 139 (54) |
| . | λ (%) . | κ (%) . | Median iFLC level, mg/L . | iFLC >100 mg/L (%) . | Urine iFLC >200 mg/24 h (%) . | Thalidomide-based induction (%) . |
|---|---|---|---|---|---|---|
| FLC escape | 21 (39) | 33 (61) | 1040 | 48 (89) | 39 (72) | 23 (43) |
| PCL | 62 (34) | 121 (66) | 719.5 | 164 (89) | 118 (65) | 93 (51) |
| PO | 84 (33) | 174 (67) | 84.63 | 127 (49) | 99 (38) | 139 (54) |
iFLC, involved serum FLC level.